Article
Clinical relevance of normal and tumour cell radiosensitivity in BRCA1/BRCA2 mutation carriers: a review.
Breast (Edinburgh, Scotland) - 1 Apr 2015
Bernier Jacques, Poortmans Philip
Abstract excerpt
Women harbouring BRCA1/2 mutations are known to be at higher lifetime risk of developing breast cancer than non-carriers. Compared to mastectomy, conservative surgery is also associated, in this patient population, with a higher probability to developing recurrent ipsilateral breast cancer following primary treatment. To reduce these risks, the management of BRCA1/2 - associated cancers has therefore focused on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
